Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Amgen Inc banner

Amgen Inc
HKEX:4332

Watchlist Manager
Amgen Inc Logo
Amgen Inc
HKEX:4332
Watchlist
Price: 1 000 HKD 125.23% Market Closed
Market Cap: HK$1.1T
Write Note Create Alert

Intrinsic Value

4332 price has not been updated for more than 4 years. This may indicate that the stock has been delisted.

Is Amgen Inc undervalued or overvalued?

See the intrinsic value estimate for Amgen Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

Amgen Inc Intrinsic Value
LOCKED
Unlock
Monitor Amgen Inc
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price HK$1 000
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Amgen Inc

Fundamental Analysis

What Amgen Does

Biotechnology Health Care

Amgen is a biotechnology company that discovers, develops, manufactures, and sells prescription medicines for serious diseases. Its drugs focus on areas such as cancer, bone health, inflammation, heart disease, and rare conditions. The company’s main customers are doctors, hospitals, specialty pharmacies, and health systems that prescribe or dispense these treatments to patients.

Headquarters
United States of America US
Employees
31 500
IPO date
Jun 17, 1983
Read the full company overview
View Company Overview

Amgen has a wide economic moat

No Moat Narrow Wide

Patents and exclusive rights to sell approved medicines prevent rivals from freely copying important Amgen treatments. These protections span a broad range of medicines, allowing Amgen to defend profits across several diseases rather than depend on a single drug.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Amgen Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

AMGN Insider Trading
Buy and sell transactions by insiders

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Amgen Inc listings:
NASDAQ • USD
AMGN
 XETRA • EUR
AMG
 F • EUR
AMG
 XHAM • EUR
AMG
 BMV • MXN
AMGN
 XMUN • EUR
AMG
 SWB • EUR
AMG
 DUS • EUR
AMG
 LSE • USD
0R0T
 XHAN • EUR
AMG
Discover More
What is the Intrinsic Value of one Amgen Inc stock?

The intrinsic value for Amgen Inc (4332) under the Base Case is hidden HKD.

Is Amgen Inc stock undervalued or overvalued?

Compared with the current market price of 1 000 HKD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.